Versartis raises $55 million, files for IPO

Growth hormone play Versartis Inc. (Redwood City, Calif.) said on Tuesday that it raised $55 million in a series E round and filed to raise up to $80 million in an IPO. Morgan Stanley; Citigroup; Cowen; and Canaccord are underwriters for the IPO. Five undisclosed new investors participated in the series E round, along with existing investors Sofinnova Ventures; Aisling Capital; New Leaf Venture Partners and Advent Life Sciences. ...